Total Company Value: Trevena, Inc. (TRVN)
This chart shows the market price of Trevena, Inc. (TRVN) on the GURU.Markets platform at . The biotech firm is currently suffering from a cash crunch and a lack of revenue, which led to the delisting of its securities. At the same time, Trevena, Inc. (TRVN) holds patents for a secure hospital analgesic protected from replication. The drug's high therapeutic efficacy allows the developer to pursue premium pricing power within the pain management segment.
Trevena, Inc. (TRVN) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Trevena Inc. (TRVN)
Patent protection for selective ligands and stringent FDA oversight make the valuation of Trevena, Inc. (TRVN) dependent on regulatory risks. This enterprise value chart reflects the total acquisition cost of the business by summing market capitalization and net debt (liabilities minus cash), allowing investors to assess the asset's real value beyond standard reporting and identify overpayment in a timely manner.
Direct competitors
BIIB - Value Adjusted for Debt and Cash|NBIX - Real Price to Acquire Entire Company|RGC: Total Company Value|Total Company Value Axsome Therapeutics|ACAD (acadia-pharm.com) - Business Value|Total Company Value Xenon (XENE)|Business Value Viking Therapeutics Inc|Supernus Pharma - Enterprise Value|Total Enterprise Value Catalyst Corp CPRX|Real Price to Acquire Entire Company DNLI (Denali Therapeutics)|harmonybiosciences.com - Enterprise Value|Total Company Value Biohaven (BHVN)|AMLX: Value Adjusted for Debt and Cash|Total Company Value TRVI|Total Enterprise Value Praxis Corp|Anavex Life Sciences (AVXL) - Real Price to Acquire Entire Company|Aggregate Business Value CBLL|Prothena Biosciences (PRTA) - Total Company Value|Value Adjusted for Debt and Cash alector.com (ALEC)|ANNX: Enterprise Value|OMER - Total Enterprise Value|NGNE - Real Price to Acquire Entire Company|ACIU - Total Company Value|Enterprise Value VYGR|NMRA (Neumora) - Total Enterprise Value|Total Company Value Scilex Holding Co. (SCLX)|Business Value Tevogen Bio Inc.|Enterprise Value ACOG|Enterprise Value Cognition Therapeutics Inc. CGTX|Real Price to Acquire Entire Company Inhibikase Therapeutics, Inc.|Value Adjusted for Debt and Cash Cassava Sciences Inc SAVA|Enterprise Value ASRT (Assertio Therapeutics)|COYA: Company Buyout Price|Total Company Value vistagen.com|Ovid Therapeutics (OVID) - Business Value|Enterprise Value ABOS|Real Price to Acquire Entire Company CervoMed, Inc. (CRVO)|ATHE (Alterity Therapeutics) - Real Price to Acquire Entire Company|Company Buyout Price clene.com CLNN|Real Price to Acquire Entire Company PepGen (PEPG)|Jupiter Neurosciences, Inc. - Aggregate Business Value|Total Company Value Relmada Therapeutics, Inc. (RLMD)|Annovis Bio Inc (ANVS) - Value Adjusted for Debt and Cash|gracetx.com (GRCE) - Real Price to Acquire Entire Company|AIFF (Firefly Neuro) - Total Company Value|Total Company Value ANEW Medical (KLTO)|Business Value NRSN|Total Company Value Reviva Pharmaceuticals Holdings, Inc. RVPH|Business Value metaviatx.com (MTVA)|NRXS: Enterprise Value|HSDT - Total Enterprise Value|Passage Bio Corp - Real Price to Acquire Entire Company|NEUP: Enterprise Value|Total Company Value Minerva Neurosciences, Inc. NERV|ATHA (Athira Pharma Inc) - Value Adjusted for Debt and Cash|Total Company Value ADXN (Addex Therapeutics, Ltd.)|Total Enterprise Value Alzamend (ALZN)|Real Price to Acquire Entire Company Cyclerion Therapeutics|Aggregate Business Value PTIX (protagenic.com)|Total Company Value Pasithea Therapeutics Corp.|Value Adjusted for Debt and Cash Cortigent Inc CRGT|ATXI (Avenue Therapeutics, Inc) - Enterprise Value|BrainStorm Cell Therapeutics Inc. (BCLI) - Total Enterprise Value|Cara Therapeutics, Inc. (CARA) - Real Price to Acquire Entire Company|chromocell.com (CHRO) - Total Company Value|Enterprise Value ELYM (Eliem Therapeutics, Inc.)|Total Enterprise Value ITCI|Total Company Value Longboard Pharma LBPH|Business Value Marinus Pharma (MRNS)|Enterprise Value NKGN (NKGen Biotech, Inc.)|NRBO - Enterprise Value|Real Price to Acquire Entire Company Sage Therapeutics (SAGE)|SNPX - Value Adjusted for Debt and Cash|vigilneuro.com - Enterprise Value|WENA (anewmeds.com) - Company Buyout Price|Total Company Value Cerevel Therapeutics (CERE)